Jumpcode Genomics News and Activities

View the org chart displaying its 8 main executives

Most searched biographies at Jumpcode Genomics

• Mike Salter, President and Chief Executive Officer
• Dan Kidle, Director
• Court Turner, Director

Create your alert
to follow the executive moves at Jumpcode Genomics.

Jumpcode Genomics has 2,415 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).

Popular M&A news in Biotechnology

• RQ Biotechnology has just announced a $86 Million fundraising (posted on June 24 2026).
• Boundless Bio has filed its IPO. Its stock ticker will be AATD. (posted on June 23 2026).
• Boundless Bio will change its company name to Serapha Bio on Dec 31, 2026. (posted on June 23 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Carl Gordon - Director at Odyssey Therapeutics
• Jan Van de Winkel - President and Chief Executive Officer at Genmab

Learn more about the Biotechnology industry

Press releases by Jumpcode Genomics

Social media about Jumpcode Genomics

• Jumpcode Genomics on Wikipedia, Google News & Yahoo Finance
• Jumpcode Genomics on LinkedIn, X (Twitter) & YouTube